NS · Healthcare

Sunrest Lifescience Ltd (SUNREST)

Pharmaceuticals & Biotechnology

Sunrest Lifescience Ltd (SUNREST) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $279.40M, P/E ratio is 9.42. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for SUNREST

Market cap

$279.40M

P/E ratio

9.42

Sunrest Lifescience Ltd (SUNREST) — FAQ

What is Sunrest Lifescience Ltd's market cap?

Sunrest Lifescience Ltd (SUNREST) has a reported market cap of $279.40M (data as of 2026-07-10).

What is SUNREST's P/E ratio?

The price-to-earnings (P/E) ratio for Sunrest Lifescience Ltd (SUNREST) is 9.42 (data as of 2026-07-10).

Does Sunrest Lifescience Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Sunrest Lifescience Ltd (SUNREST). Check the MyAverix Finance app for the latest dividend data.

What sector is Sunrest Lifescience Ltd in?

Sunrest Lifescience Ltd (SUNREST) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).

What exchange is SUNREST listed on?

SUNREST is listed on NS.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

09R (09R) 10X GENOMICS DL -00001 (1KJ) 160 Health International Ltd (2656) 1CM INC. (IQ70) 2cureX AB (2CUREX) 3-D Matrix Ltd (DMTRF) 3D Global Biotech Inc. (6808) 3D Medicines Inc (1244)